Merck is headed for its best yearly gain in more than two decades, making it the top-performing drugmaker in the S&P 500 in 2022 https://t.co/iGDRphFHgE— Bloomberg (@business) December 30, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


